GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Daxor Corp (FRA:DX5) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Daxor (FRA:DX5) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 15, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Daxor Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Daxor's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Daxor's Future 3-5Y EPS without NRI Growth Rate

For the Medical Instruments & Supplies subindustry, Daxor's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Daxor's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Daxor's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Daxor's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Daxor  (FRA:DX5) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Daxor Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Daxor's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Daxor Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Daxor Corp (FRA:DX5) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
FEMY POCI RVP IMTH NEPH NXGL HBIO BNGO AKYA EKSO ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
DXR:USA
Address
109 Meco Lane, Oak Ridge, TN, USA, 37830
Website
https://www.daxor.com
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Daxor Headlines

No Headlines